MAGE antigens: therapeutic targets in hepatocellular carcinoma?

Author： Sarobe P.   Feijoo E.   Alfaro C.   Mazzolini G.   Melero I.  

Publisher： Elsevier

ISSN： 0168-8278

Source： Journal of Hepatology, Vol.40, Iss.1, 2004-01, pp. : 155-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular Targets for Prevention of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 20, Iss. 1, 2002-07 ,pp. : 81-90

Karger

Access to resources Recommend Favorite

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

By  

Liver Cancer, Vol. 6, Iss. 1, 2016-11 ,pp. : 16-26

Karger

Access to resources Recommend Favorite

Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 321-325

Karger

Access to resources Recommend Favorite

Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions

By  

Gastrointestinal Tumors, Vol. 1, Iss. 3, 2014-07 ,pp. : 135-145

Karger

Access to resources Recommend Favorite

Screening for hepatocellular carcinoma in cirrhosis

By Bolondi L.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1076-1084

Elsevier

Access to resources Recommend Favorite